Crossmark

Risk stratification utilizing sequential organ failure assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC)

Crossref DOI link: https://doi.org/10.1038/s41598-023-49855-y

Published Online: 2023-12-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iba, Toshiaki http://orcid.org/0000-0002-0255-4088
Maier, Cheryl L. http://orcid.org/0000-0003-4044-2674
Tanigawa, Tomoki

Levy, Jerrold H. http://orcid.org/0000-0003-3766-4962
License Information

Text and Data Mining valid from 2023-12-15

Version of Record valid from 2023-12-15
More Information

Article History

Received: 21 September 2023

Accepted: 12 December 2023

First Online: 15 December 2023

Competing interests

: T.I. participated on advisory boards of Japan Blood Products Organization, Asahi Kasei Pharmaceuticals, and Toray Medical. T.T. is an employee of Japan Blood Products Organization. CLM. has no disclosures. J.H.L. serves on the Steering or Advisory Committees for Merck, Octapharma, Werfen.

Document is current

Any future updates will be listed below